2025-521460-36-00RecruitingPhase 4
Prospective randomized study on sexual health and self-perceived quality of life (PROMs) in patients treated for cervical cancer
Source: EU CTIS (euclinicaltrials.eu) · Last updated 20 Aug 2026
Brief summary (registry, in English)
To assess the improvement in sexual function and self-perceived quality of life using PROMs (Patient-Reported Outcomes) in patients treated for cervical cancer who undergo a multimodal intervention in the sexual sphere and lifestyle compared to those who undergo care within routine clinical practice.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 14 Mar 2025
- Start date
- 8 May 2026
- Lead sponsor
- Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
- Diseases
- Cervical cancer
- EU CT number
- 2025-521460-36-00
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 120
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adult women treated for cervical cancer who had a complete response and have been sexually active in the last 12 months. It tests extra support for sexual health and lifestyle.
- Age
- 18 years or older (women of legal age)
- Sex
- Women only
- Disease stage
- Primary cervical cancer, FIGO stage I-III (initial or locally advanced), squamous, adenocarcinoma or adenosquamous type
- Earlier treatment
- Treated with surgery and/or radiotherapy, with or without systemic treatment, in a gynaecological oncology unit in Spain; complete response after treatment
Main reasons for not taking part
- Pregnancy or breastfeeding
- Partial response after treatment
- Fertility-sparing treatment (trachelectomy or conization)
- Palliative treatment
- Contraindications to vaginal estrogens
Read by machine on 9 Nov 2026.
Who cannot take part
Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.
Age
- Patients under 18 years of age
Other
- Pregnancy or breastfeeding.
- Partial response after completion of oncospecific treatment.
- Patients with premalignant pathology.
- Diagnosis of a tumor of non-cervical origin or atypical histologies.
- Impossibility of completing the questionnaires included in the protocol autonomously.
- Contraindications to the use of vaginal estrogens.
- Patients undergoing fertility-sparing treatment (trachelectomy or conization).
- Patients undergoing palliative treatment.
Who the study is looking for
- Women of legal age
- Patients with primary cervical cancer stage FIGO I-III (initial or locally advanced) of squamous histology, adenocarcinoma or adenosquamous.
- Patients treated for cancer with surgery and/or radiotherapy ± systemic treatment in the Gynaecological Oncology Units of hospitals in Spain.
- Complete response after oncospecific treatment was obtained.
- Signature of the informed consent (IC) by the patient or responsible family member.
- Patients who have been sexually active within the last 12 month
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Clinic de Barcelona | Barcelona | Spain | Recruiting |
| Hospital Vall d'Hebron | Barcelona | Spain | Recruiting |
| Hospital Clínico San Carlos | Madrid | Spain | Recruiting |
| Hospital La Paz | Madrid | Spain | Recruiting |
| Hospital Universitario 12 de Octubre | Madrid | Spain | Recruiting |
| Hospital Universitario de Navarra | Pamplona | Spain | Recruiting |
| Hospital Universitario Y Politecnico La Fe | Valencia | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.